Back to Search
Start Over
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
- Source :
- EClinicalMedicine, Vol 71, Iss , Pp 102564- (2024)
- Publication Year :
- 2024
- Publisher :
- Elsevier, 2024.
- Subjects :
- Medicine (General)
R5-920
Subjects
Details
- Language :
- English
- ISSN :
- 25895370
- Volume :
- 71
- Issue :
- 102564-
- Database :
- Directory of Open Access Journals
- Journal :
- EClinicalMedicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.377d8aad4882472db54c2cd4b6fbb9b1
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.eclinm.2024.102564